Dostinex (cabergoline) 0.5 mg tablets, 8 tablets — original (Pfizer, USA) Dostinex (cabergoline) Targeted cancer therapy. Delivery from Europe within 4-5 days, storage conditions observed, payment upon receipt. Order by calling +380996042415.

Interchangeable drugs with the same active ingredient:

Alactin

Dostinex

Caberlone

Indications:

Inhibition/suppression of physiological lactation

Inhibition of physiological postpartum lactation immediately after childbirth or to suppress lactation that has established in the following cases:

after childbirth, if the mother decides not to breastfeed or when breastfeeding is contraindicated for the mother or child for medical reasons;

after stillbirth or abortion.

Treatment of hyperprolactinemic conditions

Disorders associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation, and galactorrhea. Treatment of patients with prolactin-secreting pituitary adenomas (micro- and macroprolactinomas), idiopathic hyperprolactinemia or empty sella syndrome with concomitant hyperprolactinemia, which are the underlying pathological conditions causing the above-mentioned clinical manifestations.